Birch Hill Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Birch Hill Investment Advisors's GILD Position: Q2 2017 in Review
Birch Hill Investment Advisors sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 2,200 shares — an estimated $149K sold.
Birch Hill Investment Advisors first reported a position in GILD in Q3 2013 and held it in 12 quarters. The position peaked at $399K in Q2 2015. 1,520 funds tracked by Wall St. Rank hold GILD as of Q2 2017.
- Birch Hill Investment Advisors reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
- Birch Hill Investment Advisors sold 2,200 Gilead Sciences shares in Q2 2017, an estimated $149K.
- Birch Hill Investment Advisors first reported a position in Gilead Sciences in Q3 2013 and held it in 12 quarters.
- Birch Hill Investment Advisors's Gilead Sciences position peaked at $399K in Q2 2015.
- 1,520 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.
Based on Birch Hill Investment Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.